Search Results - "VITAK, Bedrich"

Effectiveness of population‐based service screening with mammography for women ages 40 to 49 years by Hellquist, Barbro Numan, Duffy, Stephen W., Abdsaleh, Shahin, Björneld, Lena, Bordás, Pál, Tabár, László, Viták, Bedrich, Zackrisson, Sophia, Nyström, Lennarth, Jonsson, Håkan

“…BACKGROUND: The effectiveness of mammography screening for women ages 40 to 49 years still is questioned, and few studies of the effectiveness of service…”
Get full text

Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades by TABAR, László, VITAK, Bedrich, FOHLIN, Helena, SMITH, Robert A, DUFFY, Stephen W, HSIU-HSI CHEN, Tony, MING-FANG YEN, Amy, COHEN, Anders, TOT, Tibor, YUEH-HSIA CHIU, Sherry, LI-SHENG CHEN, Sam, CHING-YUAN FANN, Jean, ROSELL, Johan

“…To estimate the long-term (29-year) effect of mammographic screening on breast cancer mortality in terms of both relative and absolute effects. This study was…”
Get full text

Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort by Hellquist, Barbro Numan, Duffy, Stephen W, Abdsaleh, Shahin, Björneld, Lena, Bordás, Pál, Tabár, László, Viták, Bedrich, Zackrisson, Sophia, Nyström, Lennarth, Jonsson, Håkan

“…The effectiveness of mammography screening for women ages 40 to 49 years still is questioned, and few studies of the effectiveness of service screening for…”
Get full text

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening by Tabar, Laszlo, Yen, Ming-Fang, Vitak, Bedrich, Chen, Hsiu-Hsi Tony, Smith, Robert A, Duffy, Stephen W

“…The long term effect of mammographic service screening is not well established. We aimed to assess the long-term effect of mammographic screening on death from…”
Get full text

Estimates of overdiagnosis from two trials of mammographic screening for breast cancer by Duffy, S, Agbaje, O, Tabar, L, Bedrich, Vitak, Bjurstam, N, Björneld, L, Myles, J, Warwick, J

“…Randomised controlled trials have shown that the policy of mammographic screening confers a substantial and significant reduction in breast cancer mortality…”
Get full text

Time‐dependent effects on survival in breast carcinoma by Warwick, Jane, Tabàr, Lazlo, Vitak, Bedrich, Duffy, Stephen W.

“…BACKGROUND Tumor size, lymph node status, and histologic grade are reported to be important predictors of survival in the first 5 years after the diagnosis of…”
Get full text

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England by Duffy, Stephen W, Tabar, Laszlo, Olsen, Anne Helene, Vitak, Bedrich, Allgood, Prue C, Chen, Tony H H, Yen, Amy M F, Smith, Robert A

“…To estimate the absolute numbers of breast cancer deaths prevented and the absolute numbers of tumours overdiagnosed in mammographic screening for breast…”
Get more information

Beyond randomized controlled trials : organized mammographic screening substantially reduces breast carcinoma mortality by TABAR, Laszlo, VITAK, Bedrich, CHEN, Hsiu-Hsi Tony, YEN, Ming-Fang, DUFFY, Stephen W, SMITH, Robert A

“…The efficacy of mammographic screening in the reduction of breast carcinoma mortality has been demonstrated in randomized controlled trials. However, the…”
Get full text

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer by Duffy, Stephen W, Agbaje, Olorunsola, Tabar, Laszlo, Vitak, Bedrich, Bjurstam, Nils, Björneld, Lena, Myles, Jonathan P, Warwick, Jane

“…Randomised controlled trials have shown that the policy of mammographic screening confers a substantial and significant reduction in breast cancer mortality…”
Get full text

The natural history of breast carcinoma : What have we learned from screening? by TABAR, L, DUFFY, S. W, VITAK, B, CHEN, H.-H, PREVOST, T. C

“…The availability of breast carcinoma data from trials of mammographic screening provides an opportunity to study the natural history of breast carcinoma. The…”
Get full text

The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up by Tabár, L, Vitak, B, Chen, H H, Duffy, S W, Yen, M F, Chiang, C F, Krusemo, U B, Tot, T, Smith, R A

“…The benefit of invitation to mammographic screening observed in this trial is maintained as a highly significant 32% reduction in breast cancer mortality…”
Get more information

Time-dependent effects on survival in breast carcinoma: Results of 20 years of follow-up from the Swedish two-county study by WARWICK, Jane, TABAR, Lazlo, VITAK, Bedrich, DUFFY, Stephen W

“…Tumor size, lymph node status, and histologic grade are reported to be important predictors of survival in the first 5 years after the diagnosis of invasive…”
Get full text

Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program by Hofvind, Solveig, Skaane, Per, Vitak, Bedrich, Wang, Hege, Thoresen, Steinar, Eriksen, Liv, Bjørndal, Hilde, Braaten, Audun, Bjurstam, Nils

“…To retrospectively investigate whether different review designs have an influence on the estimate of missed interval cancer in a population-based breast cancer…”
Get more information

Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography? by Duffy, Stephen W, Tabar, Laszlo, Vitak, Bedrich, Warwick, Jane

“…In some limited-resource areas, a state-of-the-art mammography program is not affordable. In such circumstances, one might consider a less resource-intensive,…”
Get more information

Interval cancers in the Norwegian breast cancer screening program: Frequency, characteristics and use of HRT by Wang, Hege, Bjurstam, Nils, Bjørndal, Hilde, Braaten, Audun, Eriksen, Liv, Skaane, Per, Vitak, Bedrich, Hofvind, Solveig, Thoresen, Steinar Ø.

“…Breast cancers diagnosed between screening examinations among women who attend a breast cancer screening program are defined as interval cancers. The Norwegian…”
Get full text

Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes by Duffy, Stephen W., Cuzick, Jack, Tabar, Laszlo, Vitak, Bedrich, Hsiu-Hsi Chen, Tony, Yen, Ming-Fang, Smith, Robert A.

“…In the evaluation of uncontrolled service screening programmes for cancer, the case-control design is sometimes used, in which people who die from the disease…”
Get full text

Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy by Johansson, Patrik, Fohlin, Helena, Arnesson, Lars-Gunnar, Dufmats, Monika, Nordenskjöld, Kerstin, Nordenskjöld, Bo, Stål, Olle

“…Continuous minor steps of improvement in the management of breast cancer have resulted in decreased mortality rates during the last decades. The aim of this…”
Get more information

Mammographic screening: A key factor in the control of breast cancer by TABAR, Laszlo, SMITH, Robert A, VITAK, Bedrich, YEN, Ming-Fang, CHEN, Tony Hsiu-Hsi, WARWICK, Jane, MYLES, Jonathan P, DUFFY, Stephen W

Get full text

Östergötland mammographic screening programme: Compliance, referral rate, and risk of interval breast cancer after a negative screen by Vitak, Bedrich, Carstensen, John, Stål, Olle

Get full text

Beyond randomized controlled trials by Tabár, László, Vitak, Bedrich, Chen, Hsiu‐Hsi Tony, Yen, Ming‐Fang, Duffy, Stephen W., Smith, Robert A.

“…BACKGROUND The efficacy of mammographic screening in the reduction of breast carcinoma mortality has been demonstrated in randomized controlled trials…”
Get full text